Global Pneumatic Nebulizers Market by Product (Vented, Breath-actuated), by End-use (Home Healthcare, Hospitals & Clinics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global pneumatic nebulizers sales were valued at USD 644.34 Million in 2020. This market is forecast to grow at 6.0% compound annual growth rate (CAGR). Market growth is expected to be driven by the rising incidence of chronic respiratory conditions, growing demand for home healthcare products, and a growing geriatric population. The CDC has published statistics that indicate that asthma affects 18.4 million Americans. All industries have been affected by the COVID-19 pandemic, including the market for pneumatic nebulizers. Patients with COPD or asthma who knew about the possibility of COVID-19 being airborne were cautious about using inhaled medication, as they are considered to be a source of virus transmission and immunosuppression.
All such patients were advised by doctors to use their prescribed inhaled medication, including nebulizers, as usual. The overall impact of COVID-19 was therefore minimal. The availability of small, portable pneumatic nebulizers that are suitable for home use and the technological improvements in these devices to reduce their sound and improve their functionality are driving their popularity in in-home healthcare. These devices are also preferred by third-party payers such as insurance companies because they offer quality healthcare services at a lower cost. These factors will likely increase adoption during the forecast period.
Product Insights
In 2020, the revenue share for the breath-actuated product segment was over 64%. Breath-actuated nebulizers have higher drug delivery capacities and lower dosage wastage. This segment is expected to be the largest in the market for advanced inhalation therapy over the forecast period. Its popularity has been driven by its affordability and ease of integration with vented pneumatic nebulizers. Innovative products are the focus of key players. Ventec Life Systems was approved by the U.S. FDA in April 2017 for VOCSN (510(k), clearance). This device delivers five respiratory therapies, including suction, oxygen, cough, and ventilation.
End-use Insights
In 2020, the hospitals and clinics segment was dominant in the market with a 66% revenue share. Hospitals are an important part of the healthcare industry and provide a significant revenue source for the whole sector. Multiple companies spend significant efforts to promote their products/services among hospitals, both in terms marketing strategies and revenue.
Home healthcare devices have seen a lot of popularity in recent years. This has driven the segment growth. Their popularity in home healthcare is increasing due to the availability of small nebulizers that can be used at home and technological advancements that improve their functionality. The rising elderly population and the need for lower healthcare costs are expected to increase home healthcare device adoption.
Regional Insights
In 2020, North America was responsible for more than 35.0% of the total revenue. The American Lung Association (ALA) estimates that approximately 24 million Americans suffer from COPD. The growth of the region's market is also being boosted by the increase in the geriatric population. China was the region's largest market in terms of revenue.
Japan's significant increase in geriatric population is driving product demand and supporting regional growth. Asia has a higher burden of COPD than developed Western countries. Japan has 90% of COPD patients who have smoked. It is also expected that countries like India and China will have significant numbers of people suffering from pulmonary disease.
Share Insights & Key Companies
Globally, the market is very competitive. Koninklijke Philips N.V. is the most prominent participant in this market. Omron Corp. and Koninklijke Philips N.V. are key players in product launches, acquisitions and partnerships that give them a competitive advantage over their competitors. In January 2020, OMRON Corp. opened the Automation Center Tokyo (ATC–TOKYO). Customers can now join the company and find solutions to any production problems through this center. The following are some of the most prominent players in the global pneumatic-nebulizers market:
-
Koninklijke Philips N.V.
-
Omron Corp.
-
PARI Pharma
-
General Electric Company
-
Allied Healthcare Products, Inc.
-
BD (Becton, Dickinson & Company).
-
GF Health Products, Inc.
-
Medline Industries, Inc.
-
Briggs Healthcare
-
Vectura Group Plc
Up Market Research published a new report titled “Pneumatic Nebulizers Market research report which is segmented by Product (Vented, Breath-actuated), by End-use (Home Healthcare, Hospitals & Clinics), By Players/Companies BD (Becton Dickinson & Company), PARI Pharma, Koninklijke Philips NV, General Electric Company, Briggs Healthcare, GF Health Products Inc, Vectura Group Plc, Allied Healthcare Products Inc, Medline Industries Inc, Omron Corp”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Pneumatic Nebulizers Market Research Report |
| By Product | Vented, Breath-actuated |
| By End-use | Home Healthcare, Hospitals & Clinics |
| By Companies | BD (Becton Dickinson & Company), PARI Pharma, Koninklijke Philips NV, General Electric Company, Briggs Healthcare, GF Health Products Inc, Vectura Group Plc, Allied Healthcare Products Inc, Medline Industries Inc, Omron Corp |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 225 |
| Number of Tables & Figures | 158 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Pneumatic Nebulizers Market Report Segments:
The market is segmented by Product (Vented, Breath-actuated), by End-use (Home Healthcare, Hospitals & Clinics).
Pneumatic Nebulizers Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pneumatic Nebulizers Market
Overview of the regional outlook of the Pneumatic Nebulizers Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Pneumatic Nebulizers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Pneumatic Nebulizers Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Vented
2. Breath-actuated
7. By End-use:1. Home Healthcare
2. Hospitals & Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pneumatic Nebulizers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Pneumatic Nebulizers Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pneumatic Nebulizers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pneumatic Nebulizers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pneumatic Nebulizers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pneumatic Nebulizers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pneumatic Nebulizers Market Size & Forecast, 2018-2028
4.5.1 Pneumatic Nebulizers Market Size and Y-o-Y Growth
4.5.2 Pneumatic Nebulizers Market Absolute $ Opportunity
Chapter 5 Global Pneumatic Nebulizers Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Pneumatic Nebulizers Market Size Forecast by Product
5.2.1 Vented
5.2.2 Breath-actuated
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Pneumatic Nebulizers Market Analysis and Forecast by End-use
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End-use
6.1.2 Basis Point Share (BPS) Analysis by End-use
6.1.3 Absolute $ Opportunity Assessment by End-use
6.2 Pneumatic Nebulizers Market Size Forecast by End-use
6.2.1 Home Healthcare
6.2.2 Hospitals & Clinics
6.3 Market Attractiveness Analysis by End-use
Chapter 7 Global Pneumatic Nebulizers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pneumatic Nebulizers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pneumatic Nebulizers Analysis and Forecast
9.1 Introduction
9.2 North America Pneumatic Nebulizers Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pneumatic Nebulizers Market Size Forecast by Product
9.6.1 Vented
9.6.2 Breath-actuated
9.7 Basis Point Share (BPS) Analysis by Product
9.8 Absolute $ Opportunity Assessment by Product
9.9 Market Attractiveness Analysis by Product
9.10 North America Pneumatic Nebulizers Market Size Forecast by End-use
9.10.1 Home Healthcare
9.10.2 Hospitals & Clinics
9.11 Basis Point Share (BPS) Analysis by End-use
9.12 Absolute $ Opportunity Assessment by End-use
9.13 Market Attractiveness Analysis by End-use
Chapter 10 Europe Pneumatic Nebulizers Analysis and Forecast
10.1 Introduction
10.2 Europe Pneumatic Nebulizers Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pneumatic Nebulizers Market Size Forecast by Product
10.6.1 Vented
10.6.2 Breath-actuated
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
10.10 Europe Pneumatic Nebulizers Market Size Forecast by End-use
10.10.1 Home Healthcare
10.10.2 Hospitals & Clinics
10.11 Basis Point Share (BPS) Analysis by End-use
10.12 Absolute $ Opportunity Assessment by End-use
10.13 Market Attractiveness Analysis by End-use
Chapter 11 Asia Pacific Pneumatic Nebulizers Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pneumatic Nebulizers Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pneumatic Nebulizers Market Size Forecast by Product
11.6.1 Vented
11.6.2 Breath-actuated
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
11.10 Asia Pacific Pneumatic Nebulizers Market Size Forecast by End-use
11.10.1 Home Healthcare
11.10.2 Hospitals & Clinics
11.11 Basis Point Share (BPS) Analysis by End-use
11.12 Absolute $ Opportunity Assessment by End-use
11.13 Market Attractiveness Analysis by End-use
Chapter 12 Latin America Pneumatic Nebulizers Analysis and Forecast
12.1 Introduction
12.2 Latin America Pneumatic Nebulizers Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pneumatic Nebulizers Market Size Forecast by Product
12.6.1 Vented
12.6.2 Breath-actuated
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
12.10 Latin America Pneumatic Nebulizers Market Size Forecast by End-use
12.10.1 Home Healthcare
12.10.2 Hospitals & Clinics
12.11 Basis Point Share (BPS) Analysis by End-use
12.12 Absolute $ Opportunity Assessment by End-use
12.13 Market Attractiveness Analysis by End-use
Chapter 13 Middle East & Africa (MEA) Pneumatic Nebulizers Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pneumatic Nebulizers Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pneumatic Nebulizers Market Size Forecast by Product
13.6.1 Vented
13.6.2 Breath-actuated
13.7 Basis Point Share (BPS) Analysis by Product
13.8 Absolute $ Opportunity Assessment by Product
13.9 Market Attractiveness Analysis by Product
13.10 Middle East & Africa (MEA) Pneumatic Nebulizers Market Size Forecast by End-use
13.10.1 Home Healthcare
13.10.2 Hospitals & Clinics
13.11 Basis Point Share (BPS) Analysis by End-use
13.12 Absolute $ Opportunity Assessment by End-use
13.13 Market Attractiveness Analysis by End-use
Chapter 14 Competition Landscape
14.1 Pneumatic Nebulizers Market: Competitive Dashboard
14.2 Global Pneumatic Nebulizers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD (Becton Dickinson & Company)
14.3.2 PARI Pharma
14.3.3 Koninklijke Philips NV
14.3.4 General Electric Company
14.3.5 Briggs Healthcare
14.3.6 GF Health Products Inc
14.3.7 Vectura Group Plc
14.3.8 Allied Healthcare Products Inc
14.3.9 Medline Industries Inc
14.3.10 Omron Corp
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pneumatic Nebulizers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pneumatic Nebulizers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pneumatic Nebulizers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pneumatic Nebulizers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pneumatic Nebulizers Market Size & Forecast, 2018-2028
4.5.1 Pneumatic Nebulizers Market Size and Y-o-Y Growth
4.5.2 Pneumatic Nebulizers Market Absolute $ Opportunity
Chapter 5 Global Pneumatic Nebulizers Market Analysis and Forecast by Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Product
5.1.2 Basis Point Share (BPS) Analysis by Product
5.1.3 Absolute $ Opportunity Assessment by Product
5.2 Pneumatic Nebulizers Market Size Forecast by Product
5.2.1 Vented
5.2.2 Breath-actuated
5.3 Market Attractiveness Analysis by Product
Chapter 6 Global Pneumatic Nebulizers Market Analysis and Forecast by End-use
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End-use
6.1.2 Basis Point Share (BPS) Analysis by End-use
6.1.3 Absolute $ Opportunity Assessment by End-use
6.2 Pneumatic Nebulizers Market Size Forecast by End-use
6.2.1 Home Healthcare
6.2.2 Hospitals & Clinics
6.3 Market Attractiveness Analysis by End-use
Chapter 7 Global Pneumatic Nebulizers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pneumatic Nebulizers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pneumatic Nebulizers Analysis and Forecast
9.1 Introduction
9.2 North America Pneumatic Nebulizers Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pneumatic Nebulizers Market Size Forecast by Product
9.6.1 Vented
9.6.2 Breath-actuated
9.7 Basis Point Share (BPS) Analysis by Product
9.8 Absolute $ Opportunity Assessment by Product
9.9 Market Attractiveness Analysis by Product
9.10 North America Pneumatic Nebulizers Market Size Forecast by End-use
9.10.1 Home Healthcare
9.10.2 Hospitals & Clinics
9.11 Basis Point Share (BPS) Analysis by End-use
9.12 Absolute $ Opportunity Assessment by End-use
9.13 Market Attractiveness Analysis by End-use
Chapter 10 Europe Pneumatic Nebulizers Analysis and Forecast
10.1 Introduction
10.2 Europe Pneumatic Nebulizers Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pneumatic Nebulizers Market Size Forecast by Product
10.6.1 Vented
10.6.2 Breath-actuated
10.7 Basis Point Share (BPS) Analysis by Product
10.8 Absolute $ Opportunity Assessment by Product
10.9 Market Attractiveness Analysis by Product
10.10 Europe Pneumatic Nebulizers Market Size Forecast by End-use
10.10.1 Home Healthcare
10.10.2 Hospitals & Clinics
10.11 Basis Point Share (BPS) Analysis by End-use
10.12 Absolute $ Opportunity Assessment by End-use
10.13 Market Attractiveness Analysis by End-use
Chapter 11 Asia Pacific Pneumatic Nebulizers Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pneumatic Nebulizers Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pneumatic Nebulizers Market Size Forecast by Product
11.6.1 Vented
11.6.2 Breath-actuated
11.7 Basis Point Share (BPS) Analysis by Product
11.8 Absolute $ Opportunity Assessment by Product
11.9 Market Attractiveness Analysis by Product
11.10 Asia Pacific Pneumatic Nebulizers Market Size Forecast by End-use
11.10.1 Home Healthcare
11.10.2 Hospitals & Clinics
11.11 Basis Point Share (BPS) Analysis by End-use
11.12 Absolute $ Opportunity Assessment by End-use
11.13 Market Attractiveness Analysis by End-use
Chapter 12 Latin America Pneumatic Nebulizers Analysis and Forecast
12.1 Introduction
12.2 Latin America Pneumatic Nebulizers Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pneumatic Nebulizers Market Size Forecast by Product
12.6.1 Vented
12.6.2 Breath-actuated
12.7 Basis Point Share (BPS) Analysis by Product
12.8 Absolute $ Opportunity Assessment by Product
12.9 Market Attractiveness Analysis by Product
12.10 Latin America Pneumatic Nebulizers Market Size Forecast by End-use
12.10.1 Home Healthcare
12.10.2 Hospitals & Clinics
12.11 Basis Point Share (BPS) Analysis by End-use
12.12 Absolute $ Opportunity Assessment by End-use
12.13 Market Attractiveness Analysis by End-use
Chapter 13 Middle East & Africa (MEA) Pneumatic Nebulizers Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pneumatic Nebulizers Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pneumatic Nebulizers Market Size Forecast by Product
13.6.1 Vented
13.6.2 Breath-actuated
13.7 Basis Point Share (BPS) Analysis by Product
13.8 Absolute $ Opportunity Assessment by Product
13.9 Market Attractiveness Analysis by Product
13.10 Middle East & Africa (MEA) Pneumatic Nebulizers Market Size Forecast by End-use
13.10.1 Home Healthcare
13.10.2 Hospitals & Clinics
13.11 Basis Point Share (BPS) Analysis by End-use
13.12 Absolute $ Opportunity Assessment by End-use
13.13 Market Attractiveness Analysis by End-use
Chapter 14 Competition Landscape
14.1 Pneumatic Nebulizers Market: Competitive Dashboard
14.2 Global Pneumatic Nebulizers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD (Becton Dickinson & Company)
14.3.2 PARI Pharma
14.3.3 Koninklijke Philips NV
14.3.4 General Electric Company
14.3.5 Briggs Healthcare
14.3.6 GF Health Products Inc
14.3.7 Vectura Group Plc
14.3.8 Allied Healthcare Products Inc
14.3.9 Medline Industries Inc
14.3.10 Omron Corp
Segments Covered in the Report
The global Pneumatic Nebulizers market has been segmented based on
By Product
The global Pneumatic Nebulizers market has been segmented based on
By Product
- Vented
- Breath-actuated
- Home Healthcare
- Hospitals & Clinics
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- BD (Becton Dickinson & Company)
- PARI Pharma
- Koninklijke Philips NV
- General Electric Company
- Briggs Healthcare
- GF Health Products Inc
- Vectura Group Plc
- Allied Healthcare Products Inc
- Medline Industries Inc
- Omron Corp
Our Clients
Related Reports
Some other reports from this category!
